Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6801
Invesco Large Cap Growth ETF
PWB
$2.42B
| $1.05M | ﹤0.01% |
17,940
+3,202
| +22% | +$204K |
|
6802
Sable Offshore Corp
SOC
$767M
| $1.05M | ﹤0.01% |
107,514
+516
| +0.5% | +$5.05K |
|
6803
Financial Institutions
FISI
$814M
| $1.05M | ﹤0.01% |
40,441
-6,751
| -14% | -$188K |
|
|
IPG
6804
CALL
DELISTED
Interpublic Group of Companies
IPG
| $1.05M | ﹤0.01% |
38,200
-14,600
| -28% | -$463K |
|
6805
National Bank Holdings
NBHC
$1.91B
| $1.05M | ﹤0.01% |
27,484
-25,126
| -48% | -$978K |
|
|
CIVI
6806
PUT
DELISTED
Civitas Resources
CIVI
| $1.05M | ﹤0.01% |
20,100
-1,500
| -7% | -$97.9K |
|
6807
CALL
KNOT Offshore Partners
KNOP
$365M
| $1.05M | ﹤0.01% |
64,200
+6,100
| +10% | +$104K |
|
6808
PUT
Amdocs
DOX
$6.19B
| $1.05M | ﹤0.01% |
+12,600
| New | +$1.04M |
|
6809
State Street SPDR S&P Emerging Markets Small Cap ETF
EWX
$695M
| $1.05M | ﹤0.01% |
+21,580
| New | +$1.13M |
|
6810
Invesco China Technology ETF
CQQQ
$3.15B
| $1.05M | ﹤0.01% |
20,781
-17,785
| -46% | -$803K |
|
6811
CALL
Enovix
ENVX
$693M
| $1.05M | ﹤0.01% |
134,400
+50,971
| +61% | +$479K |
|
6812
PDF Solutions
PDFS
$1.99B
| $1.05M | ﹤0.01% |
48,724
+30,406
| +166% | +$703K |
|
6813
CALL
RenaissanceRe
RNR
$13.4B
| $1.05M | ﹤0.01% |
6,700
-2,400
| -26% | -$363K |
|
6814
CALL
Quaker Houghton
KWR
$2.86B
| $1.05M | ﹤0.01% |
7,000
+5,600
| +400% | +$867K |
|
|
SLI
6815
CALL
Standard Lithium
SLI
$563M
| $1.05M | ﹤0.01% |
247,000
-72,600
| -23% | -$430K |
|
6816
CALL
Twist Bioscience
TWST
$7.27B
| $1.04M | ﹤0.01% |
29,900
-15,300
| -34% | -$542K |
|
|
IBHB
6817
DELISTED
iShares iBonds 2022 Term High Yield and Income ETF
IBHB
| $1.04M | ﹤0.01% |
+43,542
| New | +$1.05M |
|
6818
Nuveen Enhanced Yield US Aggregate Bond ETF
NUAG
$97.3M
| $1.04M | ﹤0.01% |
+48,506
| New | +$1.06M |
|
6819
BBVA Argentina
BBAR
$3B
| $1.04M | ﹤0.01% |
436,013
+306,960
| +238% | +$910K |
|
6820
Inseego
INSG
$71.1M
| $1.04M | ﹤0.01% |
55,061
+27,449
| +99% | +$700K |
|
|
PENG
6821
Penguin Solutions Inc
PENG
$2.99B
| $1.04M | ﹤0.01% |
63,611
+17,113
| +37% | +$390K |
|
6822
CALL
Compass Minerals
CMP
$1.04B
| $1.04M | ﹤0.01% |
29,400
-10,100
| -26% | -$500K |
|
6823
PUT
iShares Residential and Multisector Real Estate ETF
REZ
$850M
| $1.04M | ﹤0.01% |
13,000
+10,900
| +519% | +$947K |
|
6824
PUT
TPG
TPG
$8.29B
| $1.04M | ﹤0.01% |
43,500
+31,900
| +275% | +$861K |
|
|
GENY
6825
DELISTED
Principal Exchange-Traded Funds Principal Millennial Global Growth ETF
GENY
| $1.04M | ﹤0.01% |
+26,428
| New | +$1.14M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.